Research output per year
Research output per year
Personal profile
Research interests
Clinical trials in breast cancer especially in patients with triple negative disease, early-onset breast cancer, racial disparities.
Clinical interests
Medical Oncology, breast cancer, breast oncology
Fingerprint
Dive into the research topics where Foluso Ademuyiwa is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages
Iglesia, M. D., Jayasinghe, R. G., Chen, S., Terekhanova, N. V., Herndon, J. M., Storrs, E., Karpova, A., Zhou, D. C., Naser Al Deen, N., Shinkle, A. T., Lu, R. J. H., Caravan, W., Houston, A., Zhao, Y., Sato, K., Lal, P., Street, C., Martins Rodrigues, F., Southard-Smith, A. N. & Targino da Costa, A. L. N. & 40 others, , Nov 2024, In: Nature Cancer. 5, 11, p. 1713-1736 24 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Evaluation of markers of immunity in different metastatic immune microenvironments suggests more suppression within breast to liver metastases in breast cancer
Hsu, R., Al-zubeidy, B., Flores, D., Nazarian, A., Baugh, A., Gonzalez, E., Castanon, S., Xiu, J., Kang, I., Spicer, D., Lenz, H. J., Dara, L., Ademuyiwa, F. O., Korn, W. M., Irshad, S., Chan, I. S. & Roussos Torres, E. T., Jul 2024, In: Breast Cancer Research and Treatment. 206, 2, p. 245-259 15 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Low RNA disruption during neoadjuvant chemotherapy predicts pathologic complete response absence in patients with breast cancer
Cazzaniga, M. E., Ademuyiwa, F., Petit, T., Tio, J., Generali, D., Ciruelos, E. M., Califaretti, N., Poirier, B., Ardizzoia, A., Med, A. H., Med, B. L., Mouret-Reynier, M. A., Med, D. G., Isambert, N., Masetti, R., Pitre, L., Med, D. W., Augereau, P., Milani, M. & Rask, S. & 5 others, , Jan 1 2024, In: JNCI Cancer Spectrum. 8, 1, pkad107.Research output: Contribution to journal › Article › peer-review
Open Access -
Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients
Zhang, X., Goedegebuure, S. P., Chen, M. Y., Mishra, R., Zhang, F., Yu, Y. Y., Singhal, K., Li, L., Gao, F., Myers, N. B., Vickery, T., Hundal, J., McLellan, M. D., Sturmoski, M. A., Kim, S. W., Chen, I., Davidson, J. T., Sankpal, N. V., Myles, S. & Suresh, R. & 13 others, , Dec 2024, In: Genome medicine. 16, 1, 131.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN)
Ademuyiwa, F. O., Northfelt, D. W., O’Connor, T., Levine, E., Luo, J., Tao, Y., Hoog, J., Laury, M. L., Summa, T., Hammerschmidt, T., Guo, Z., Frith, A., Weilbaecher, K., Opyrchal, M., Aft, R., Clifton, K., Suresh, R., Bagegni, N., Hagemann, I. S. & Iglesia, M. D. & 1 others, , Dec 2023, In: npj Breast Cancer. 9, 1, 1.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations